Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
University of California San Diego, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
University of California San Diego, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
University of California San Diego, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
University of California San Diego, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
University of California San Diego, Medical Devices Deals, 2011 to YTD 2017 11
University of California San Diego, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 12
University of California San Diego, Pharmaceuticals & Healthcare, Deal Details 15
Asset Purchase 15
UC San Diego Health Acquires San Diego Cancer Center 15
Partnerships 16
Oxeia Biopharmaceuticals Enters Into Partnership Agreement with University of California San Diego School of Medicine 16
University of California San Diego School of Medicine Enters into Agreement with Janssen Pharma 17
Biomed Realty Trust Enters into Agreement with University of California San Diego 18
Galmed Pharma Enters into Agreement with University of California 19
Janssen Pharma Enters into Agreement with University of California, San Diego 20
AccentCare Forms Joint Venture With UC San Diego Health System 21
ChemDiv Enters into R&D Agreement with UCSD, MIPT and SatRx 22
University of California and San Diego School of Medicine Partners with UC San Diego Moores Cancer Center 23
Pfizer Announces Co-Development Agreement With University Of California, San Diego 24
Regulus Therapeutics Enters Into Collaboration With University of California 26
Licensing Agreements 27
Creative Medical Technologies Enters into Licensing Agreement with University of California, San Diego 27
Oncternal Therapeutics Enters into Licensing Agreement with University of California 28
Curtana Pharma Enters into Licensing Agreement with University of California San Diego 29
Abreos Biosciences Enter into License Agreement with University of California San 30
RetroSense Therapeutics Enters into Licensing Agreement with University of California San Diego 31
DesignMedix Enters into Licensing Agreement with University of California, San Diego 32
PsychoGenics Enters into Licensing Agreement with University of California, San Diego 33
Forge Therapeutics Enters into Licensing Agreement with University of California San Diego 34
PsychoGenics Enters into Licensing Agreement with University of California, San Diego School of Medicine for Transgenic Mouse Model of a-Synucleinopathies 35
PsychoGenics Enters into Licensing Agreement with University of California, San Diego School of Medicine 36
Batu Biologics Enters into Licensing Agreement with University of California, San Diego 37
PaxVax Enters into Licensing Agreement with University Of California, San Diego 38
SomPharma Enters into Licensing Agreement with University of California, San Diego 39
Solstice Biologics Enters Into Licensing Agreement With University of California, San Diego 40
Arytha Biosciences Enters into Licensing Agreement with University of California, San Diego 41
DevaCell Enters into Licensing Agreement with University of California, San Diego 42
Sanofi Pasteur Enters Into Licensing Agreement With University of California, San Diego 43
University of California San Diego – Key Competitors 44
University of California San Diego – Key Employees 45
University of California San Diego – Locations And Subsidiaries 46
Head Office 46
Other Locations & Subsidiaries 46
Recent Developments 48
Strategy And Business Planning 48
Feb 08, 2016: UC San Diego Launches New Nonalcoholic Fatty Liver Disease Research Center 48
Government and Public Interest 50
Oct 23, 2017: Penn Radiology Researcher Awarded $3.9 Million to Help Develop First Three-Dimensional Digital Atlas of Brain Cells 50
Oct 17, 2017: Pair of Discoveries Illuminate New Paths to Flu and Anthrax Treatments 51
Sep 27, 2017: Camino Pharma Co-founder Receives $10.8 Million Grant for Development of Potential Drug for Cocaine and Nicotine Addiction 53
Sep 13, 2017: Researchers develop new strategy to target KRAS mutant cancer 54
Jul 31, 2017: Organovo and UC San Diego Receive $1.7 Million Grant From National Institutes of Health to Study Liver Disease 55
Apr 21, 2017: Using CRISPR to Reverse Retinitis Pigmentosa and Restore Visual Function 56
Feb 07, 2017: Cystinosis Research Foundation Grants Support Scientific Studies on Cell Function, New Treatments and the Quest for a Cure 57
Dec 12, 2016: 3D Chemokine Receptor Study Opens Door to Finding New Anti-Inflammatory Drugs 59
Nov 18, 2016: New method helps identify antibiotics in mass spectrometry datasets 60
Nov 01, 2016: Researchers identify new drug target for gastrointestinal stromal tumors 62
Oct 17, 2016: FDA awards 21 grants to stimulate product development for rare diseases 63
Oct 04, 2016: Revolutionary Clinical Trial Initiative Focuses on Precision Medicine, Collaboration and Data Sharing to Transform Outcomes for All Pancreatic Cancer Patients 65
Sep 22, 2016: Kenneth Rainin Foundation Awards Over $3 Million to High-Risk, High Reward Inflammatory Bowel Disease Research Projects 67
Sep 09, 2016: Six-day Clinical Trial Finds Integrative Medicine Program Alters Blood Serum 69
Sep 05, 2016: Promising drug leads identified to combat heart disease 70
Jul 21, 2016: Researchers ID cancer gene-drug combinations ripe for precision medicine 72
Jun 23, 2016: TSRI Scientists Reveal Single-Neuron Gene Landscape of the Human Brain 73
Jun 06, 2016: Novel imaging model helps reveal new therapeutic target for pancreatic cancer 75
Feb 22, 2016: Newly discovered HIV genome modification may put a twist on vaccine and drug design 76
Feb 10, 2016: Alcohol Also Damages the Liver by Allowing Bacteria to Infiltrate 77
Feb 08, 2016: Engineers 3D-print a New Lifelike Liver Tissue for Drug Screening 78
Jan 22, 2016: Biologists Develop Method for Antibiotic Susceptibility Testing 79
Jan 12, 2016: New NIH awards will support development of therapeutic alternatives to traditional antibiotics 81
Product News 83
Oct 26, 2017: Vanderbilt leads international effort to develop universal flu vaccine 83
Aug 31, 2016: Takeda Launches Largest Pharmaceutical Company-Sponsored Global Observational Study of Its Kind in Multiple Myeloma 84
Apr 11, 2017: ‘Neuron-reading’ nanowires could accelerate development of drugs for neurological diseases 85
Other Significant Developments 86
Oct 26, 2017: The Human Vaccines Project Launches New Initiative To Accelerate Development Of Universally Effective Influenza Vaccines 86
Appendix 87
Methodology 87
About GlobalData 87
Contact Us 87
Disclaimer 87
University of California San Diego, Pharmaceuticals & Healthcare, Key Facts, 2015 2
University of California San Diego, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
University of California San Diego, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
University of California San Diego, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
University of California San Diego, Deals By Therapy Area, 2011 to YTD 2017 9
University of California San Diego, Medical Devices Deals, 2011 to YTD 2017 11
University of California San Diego, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 12
UC San Diego Health Acquires San Diego Cancer Center 15
Oxeia Biopharmaceuticals Enters Into Partnership Agreement with University of California San Diego School of Medicine 16
University of California San Diego School of Medicine Enters into Agreement with Janssen Pharma 17
Biomed Realty Trust Enters into Agreement with University of California San Diego 18
Galmed Pharma Enters into Agreement with University of California 19
Janssen Pharma Enters into Agreement with University of California, San Diego 20
AccentCare Forms Joint Venture With UC San Diego Health System 21
ChemDiv Enters into R&D Agreement with UCSD, MIPT and SatRx 22
University of California and San Diego School of Medicine Partners with UC San Diego Moores Cancer Center 23
Pfizer Announces Co-Development Agreement With University Of California, San Diego 24
Regulus Therapeutics Enters Into Collaboration With University of California 26
Creative Medical Technologies Enters into Licensing Agreement with University of California, San Diego 27
Oncternal Therapeutics Enters into Licensing Agreement with University of California 28
Curtana Pharma Enters into Licensing Agreement with University of California San Diego 29
Abreos Biosciences Enter into License Agreement with University of California San 30
RetroSense Therapeutics Enters into Licensing Agreement with University of California San Diego 31
DesignMedix Enters into Licensing Agreement with University of California, San Diego 32
PsychoGenics Enters into Licensing Agreement with University of California, San Diego 33
Forge Therapeutics Enters into Licensing Agreement with University of California San Diego 34
PsychoGenics Enters into Licensing Agreement with University of California, San Diego School of Medicine for Transgenic Mouse Model of a-Synucleinopathies 35
PsychoGenics Enters into Licensing Agreement with University of California, San Diego School of Medicine 36
Batu Biologics Enters into Licensing Agreement with University of California, San Diego 37
PaxVax Enters into Licensing Agreement with University Of California, San Diego 38
SomPharma Enters into Licensing Agreement with University of California, San Diego 39
Solstice Biologics Enters Into Licensing Agreement With University of California, San Diego 40
Arytha Biosciences Enters into Licensing Agreement with University of California, San Diego 41
DevaCell Enters into Licensing Agreement with University of California, San Diego 42
Sanofi Pasteur Enters Into Licensing Agreement With University of California, San Diego 43
University of California San Diego, Key Competitors 44
University of California San Diego, Key Employees 45
University of California San Diego, Subsidiaries 46
